Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis (Ophthalmology. 2018;125:1332-1343). (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ophtha.2018.09.017
PubMed Identifier: 30683186
Publication URI: http://europepmc.org/abstract/MED/30683186
Type: Journal Article/Review
Volume: 126
Parent Publication: Ophthalmology
Issue: 2
ISSN: 0161-6420